Many Hands Make Light Work
March 23, 2021
Effective lung cancer treatment requires industry collaboration and good timing
1 min read
March 2021
In our March issue, we examine the impact of COVID-19 on pharma, from the use of digital platforms for communication and training to the operational challenges of producing glass vials for vaccines. In Business, we also discuss the long-lasting influence of Brexit on pharma within the UK and beyond its shores. Meanwhile, our cover feature provides a snapshot of the progress being made in neuroscience R&D. Finally, we sit down with Jason Lacombe, CEO of Veratrak, who argues the cases for the uptake of blockchain technologies.
On the Cusp of Change
March 20, 2021
Though neuroscience R&D has faced setbacks, a renewed interest in the field is helping companies draw closer to solutions for patients living with brain disorders
1 min read
Bridging the Barrier
March 20, 2021
Pharma has always had its sights set on the lofty goal of traversing the blood-brain barrier. Could nanoparticle technologies bring the industry a step closer to success?
1 min read
R&D Without Borders
March 19, 2021
Without the constraints of brick-and-mortar sites and employees, virtual biotechs could help in bringing the next generation of brain drugs to market
1 min read
Biopharma Trends to Watch
March 19, 2021
Five trends that will shape the future of biopharma manufacturing in 2021
1 min read
Business & Regulation
Regulation & Standards
Business & Trends
Supply Chain
Facilities & Equipment
Technology & Manufacturing
An Inspector Calls?
March 18, 2021
The FDA is under fire from the US GAO after the pandemic lengthened its already long inspection to-do list…
1 min read
No Deal; No More
March 15, 2021
Did the pharma industry get everything it wanted from a UK-EU Brexit deal? Were worries over border delays and shortages of medicines warranted? After years of speculation, we reveal what Brexit really means for pharma – so far.
1 min read
Manufacture
Packaging
Facilities & Equipment
Technology & Manufacturing
Drug Delivery
Bioprocessing
Biopharma
Who’s the Winner?
March 13, 2021
Announcing the Grand Winner of The Medicine Maker 2020 Innovation Awards
1 min read
V for Victory?
March 12, 2021
Controversy-ridden vaccine, Sputnik V, (finally and definitely) starts rolling review with the EMA
1 min read
Let’s cHAT About Drugs
March 11, 2021
How can we reduce the cost of pharmaceutical intermediates?
1 min read
Purifying Gene Therapy
March 10, 2021
The gene therapy industry must maximize the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction and, ultimately, cut costs. How? High-level purification.
1 min read
Selfishness and Stupidity?
March 4, 2021
We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.
1 min read
Manufacture
Small Molecules
Facilities & Equipment
Technology & Manufacturing
Formulation
Development & Clinical
Packaging
Two Grand Challenges for Pharma
March 3, 2021
A pair of medicines manufacturing initiatives are using digital technologies to improve continuous direct compression and make clinical trial supply more efficient
1 min read
Medicine Making on Mars
March 2, 2021
When astronauts are eventually sent to Mars, what will they do about medicine needs?
1 min read
Digital Discussion
December 1, 2020
To give patients timely access to novel and effective therapeutics, we must use artificial intelligence – but changing industry attitudes is no mean feat
0 min read
